Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 1:19 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1585–1608 of 18,244 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Controlled Group Clear all

Conditions: Rhinitis, Allergic, Perennial
Interventions: Fluticasone furoate nasal spray, Placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 12 Years and older
Enrollment: 315 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 12
States / cities: Baltimore, Maryland • Wheaton, Maryland • North Dartmouth, Massachusetts + 9 more

Conditions: Hemoglobin
Interventions: Radical-7 Noninvasive Hgb Monitor; Device
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Air Pollution, Indoor, Behavior
Interventions: RCT 1- Testing the Effectiveness of Marketing Messages in Increasing Willingness to Pay, RCT 3-Measure the Effects of Fuel Efficient Cookstoves on Health, Fuel Use and Time Spent Collecting Fuel, RCT 2- Testing the Effectiveness of the Novel Sales Offer and its ability to Increase Uptake of Purchasing Energy Efficient Cookstoves; Other
Lead sponsor: University of California, Berkeley; Other
Eligibility: 18 Years and older · Female only
Enrollment: 3,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Berkeley, California

Conditions: MTBI - Mild Traumatic Brain Injury
Interventions: Not listed
Lead sponsor: Salus University; Other
Eligibility: 18 Years to 35 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: Computerized Progressive Attention Training, Sham Comparator Cognitive Training; Other
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 7 Years to 12 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Acute Kidney Injury, Acute Kidney Injury (AKI)
Interventions: AKI Discharge Summary Template, Chat-Based Educational Messaging Program; Behavioral
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Glen Oaks, New York • Manhasset, New York

Conditions: Mild Dementia
Interventions: Care Partner-Assisted Intervention; Behavioral
Lead sponsor: New York University; Other
Eligibility: 60 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 2
States / cities: New York, New York • Durham, North Carolina

Conditions: Hypoxemia, Acute Mountain Sickness (AMS), Inflammation, Immune Response
Interventions: ACETAZOLAMIDE oral capsule, Placebo Arm; Drug · Device
Lead sponsor: University of California, Riverside; Other
Eligibility: 18 Years to 65 Years
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Riverside, California

Conditions: Intestinal Permeability, Inflammation, Vaccine, Typhoid Fever
Interventions: Vivotif Typhoid Oral Vaccine, Aspirin (Positive Control); Biological · Drug
Lead sponsor: USDA, Western Human Nutrition Research Center; Federal
Eligibility: 18 Years to 49 Years · Female only
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Davis, California

Conditions: Epilepsy
Interventions: Brivaracetam, Lorazepam; Drug
Lead sponsor: UCB Biopharma S.P.R.L.; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 14
States / cities: Birmingham, Alabama • Tucson, Arizona • Orlando, Florida + 10 more

Conditions: Infertility
Interventions: Acupuncture, Electro-Acupuncture; Procedure
Lead sponsor: National University of Health Sciences; Other
Eligibility: 21 Years to 45 Years · Female only
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 2
States / cities: Chicago, Illinois • Lombard, Illinois

Conditions: Atrial Fibrillation
Interventions: LOVAZA Omega 3-acid ethyl esters, LOVAZA, placebo; Drug · Other
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 70 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Type2diabetes
Interventions: Prompt-sheet, Usual education; Other
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 45 Years and older
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Autism
Interventions: Omega 3 fatty acids, Placebo; Drug · Other
Lead sponsor: University of Medicine and Dentistry of New Jersey; Other
Eligibility: 5 Years to 17 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Piscataway, New Jersey

Conditions: Primary Immune Deficiency Disorder, Common Variable Immunodeficiency, Specific Antibody Deficiency, Hypergammaglobulinemia
Interventions: Exercise Program; Other
Lead sponsor: Stockton University; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Galloway, New Jersey

Conditions: Stress Urinary Incontinence, Knowledge, Attitudes, Practice
Interventions: Educational video, Educational leaflet; Other
Lead sponsor: Felicia Lane; Other
Eligibility: 18 Years and older · Female only
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Orange, California

Conditions: Schizophrenia
Interventions: SPD489 low dose range (40mg, 80mg, and 100mg), SPD489 high dose range (120mg, 140mg and 160mg), Placebo; Drug
Lead sponsor: Shire; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 4
States / cities: Miami Springs, Florida • O'Fallon, Missouri • Saint Charles, Missouri + 1 more

Conditions: Diabetic Macular Edema
Interventions: Faricimab, Ranibizumab; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years and older
Enrollment: 229 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 60
States / cities: Phoenix, Arizona • Tucson, Arizona • Fullerton, California + 53 more

Conditions: Obesity, Major Depressive Disorder, Dysthymic Disorder, Cardiovascular Disease
Interventions: Behavior Modification for Weight Loss, Alternative Approach to Weight Loss, Cognitive-Behavior Therapy for Depression, Depression Support and Education; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 70 Years
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Cancer, Pain, Advanced Cancer
Interventions: Cancer Pain 101; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Supranuclear Palsy, Progressive
Interventions: BIIB092, Placebo; Drug
Lead sponsor: Biogen; Industry
Eligibility: 41 Years to 86 Years
Enrollment: 490 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 33
States / cities: Phoenix, Arizona • Scottsdale, Arizona • Sun City, Arizona + 25 more

Conditions: Pregnancy, Caesarean Section
Interventions: Experimental Audio Visual; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Abdominal Aortic Aneurysm
Interventions: Ovation Abdominal Stent Graft Platform; Device
Lead sponsor: TriVascular, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 225 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Stanford, California

Conditions: Healthy Male and Female Subjects
Interventions: Running, Cycling, Rugby, control group; Other
Lead sponsor: Appalachian State University; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Boone, North Carolina

Search by objective public record fields.

A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis

Noninvasive Hemoglobin Monitor in the ER

Testing New Marketing Models for Improved Cookstoves - Uganda

Validation of Clinical Outcome Measures Specific to mTBI-Related Oculomotor Disorders

Cognitive Training Trial

COordiNated CommuNication, Education, and Care Transitions After Acute Kidney Injury (CONNECT-AKI)

Care Partner Assisted Intervention to Improve Oral Health of Individuals With Mild Dementia

The Role of Acetazolamide in Mitigating Inflammation and Innate Immune Activation at High Altitude

Induction of Gut Permeability by an Oral Vaccine

A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit Setting

Electro-acupuncture and Assisted Reproductive Technology

Effects of Fish Oil on Post Ablation Arrhythmias

Promoting Alternatives to Sulfonylureas to Improve Patient Safety in Type 2 Diabetes

Omega 3 Fatty Acids in the Treatment of Children With Autism Spectrum Disorders

The Impact of Exercise on Stress, Fatigue, and Quality of Life in Individuals With Primary Immunodeficiency Disease

An Educational Video to Improve Patient Comprehension of Midurethral Sling

SPD489 Low Dose and High Dose Ranges When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia

A Study of Faricimab (RO6867461) in Participants With Center-Involving Diabetic Macular Edema

Treatment for Depressed, Obese Individuals at Risk for Cardiovascular Disease (CVD)

Cancer Pain 101: A Digital, Asynchronous Intervention of Pain Management in Advanced Cancer

Study of BIIB092 in Participants With Progressive Supranuclear Palsy

A Multimedia Presentation to Augment the Informed Consent Process for Anesthesia for Patients Undergoing Scheduled Caesarian Delivery

LUCY Study: TriVascular Evaluation of Females Who Are Underrepresented Candidates for Abdominal Aortic Aneurysm Repair

The Effect of Cycling, Running, and Playing Rugby on Three Biomarkers That May Indicate Brain Injury